Jin Linda X, Sanford Dominic E, Squires Malcolm Hart, Moses Lindsey E, Yan Yan, Poultsides George A, Votanopoulos Konstantinos I, Weber Sharon M, Bloomston Mark, Pawlik Timothy M, Hawkins William G, Linehan David C, Schmidt Carl, Worhunsky David J, Acher Alexandra W, Cardona Kenneth, Cho Clifford S, Kooby David A, Levine Edward A, Winslow Emily, Saunders Neil, Spolverato Gaya, Colditz Graham A, Maithel Shishir K, Fields Ryan C
Department of Surgery, Barnes Jewish Hospital and The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Ann Surg Oncol. 2016 Aug;23(8):2398-408. doi: 10.1245/s10434-016-5121-7. Epub 2016 Mar 22.
Postoperative complications (POCs) can negatively impact survival after oncologic resection. POCs may also decrease the rate of adjuvant therapy completion. We evaluated the impact of complications on gastric cancer survival and analyzed the combined effect of complications and adjuvant therapy on survival.
We analyzed 824 patients from 7 institutions of the U.S. Gastric Cancer Collaborative who underwent curative resection for gastric adenocarcinoma between 2000 and 2012. POC were graded using the modified Clavien-Dindo system. Survival probabilities were estimated using the method of Kaplan and Meier and analyzed using multivariate Cox regression.
Median follow-up was 35 months. The overall complication rate was 41 %. The 5-year overall survival (OS) and recurrence-free survival (RFS) of patients who experienced complications were 27 and 23 %, respectively, compared with 43 and 40 % in patients who did not have complications (p < 0.0001 for OS and RFS). On multivariate analysis, POC remained an independent predictor for decreased OS and RFS (HR 1.3, 95 % CI 1.1-1.6, p = 0.03 for OS; HR 1.3, 95 % CI 1.01-1.6, p = 0.03 for RFS). Patients who experienced POC were less likely to receive adjuvant therapy (OR 0.5, 95 % CI 0.3-0.7, p < 0.001). The interaction of complications and failure to receive adjuvant therapy significantly increased the hazard of death compared with patients who had neither complications nor adjuvant therapy (HR 2.3, 95 % CI 1.6-3.2, p < 0.001).
Postoperative complications adversely affect long-term outcomes after gastrectomy for gastric cancer. Not receiving adjuvant therapy in the face of POC portends an especially poor prognosis following gastrectomy for gastric cancer.
术后并发症(POC)会对肿瘤切除术后的生存产生负面影响。POC还可能降低辅助治疗的完成率。我们评估了并发症对胃癌生存的影响,并分析了并发症和辅助治疗对生存的联合作用。
我们分析了来自美国胃癌协作组7家机构的824例患者,这些患者在2000年至2012年间接受了胃腺癌根治性切除术。使用改良的Clavien-Dindo系统对POC进行分级。采用Kaplan-Meier法估计生存概率,并使用多变量Cox回归进行分析。
中位随访时间为35个月。总体并发症发生率为41%。发生并发症患者的5年总生存率(OS)和无复发生存率(RFS)分别为27%和23%,而未发生并发症患者的这两个比例分别为43%和40%(OS和RFS的p均<0.0001)。多变量分析显示,POC仍然是OS和RFS降低的独立预测因素(OS的HR为1.3,95%CI为1.1-1.6,p=0.03;RFS的HR为1.3,95%CI为1.01-1.6,p=0.03)。发生POC的患者接受辅助治疗的可能性较小(OR为0.5,95%CI为0.3-0.7,p<0.001)。与既无并发症又未接受辅助治疗的患者相比,并发症与未接受辅助治疗之间的相互作用显著增加了死亡风险(HR为2.3,95%CI为1.6-3.2,p<0.001)。
术后并发症对胃癌胃切除术后的长期预后产生不利影响。面对POC时未接受辅助治疗预示着胃癌胃切除术后预后特别差。